OpenAI Cuts Valuation as AI Investment Fever Cools
OpenAI is lowering its target valuation by $150 billion amid signs of investor fatigue in the AI boom. The retreat signals a broader reckoning for a sector that outpaced its earnings.
The Canary Taps Its Foot
OpenAI has lowered its target valuation from $1.4 trillion to $1.25 trillion — a $150 billion retreat that reads less like a rounding error and more like the first crack in the AI gold rush.
The adjustment, reported by the Financial Times on October 22, comes as OpenAI enters the final stage of a fundraising round led by Morgan Stanley. The company aims to raise $30 billion ahead of a planned IPO next year. Even at the reduced valuation, the $1.25 trillion figure remains roughly 50% above the $852 billion mark set in its previous round. But the direction matters more than the destination: when the most hyped startup in technology quietly concedes that its worth is less than promised, the signal extends far beyond one company.
Sources close to the process described a distinctly different atmosphere from previous rounds. Where once lead investors competed to anchor rounds with oversized commitments, this time Morgan Stanley reportedly found itself negotiating alone — or nearly so. Several other major financial institutions that had been expected to participate instead took观望 (wait-and-see) positions, according to people familiar with the discussions. The contrast with March 2026, when the $122 billion round closed in what felt like a stampede, was sharp enough to unsettle even veteran dealmakers.
Who Is Behind the Retreat?
The immediate cause is straightforward. Investor demand fell short of expectations. Multiple sources familiar with the process told the FT that customers were reluctant, and the usual frenzy surrounding an OpenAI fundraising round simply did not materialize.
“There was no sense of investors flocking,” one source said. “In the past, whenever OpenAI opened an investment opportunity, there would be a mania. This time, the response was anything but exciting.”
That description captures a market that has grown visibly older, more cautious, and more discriminating. The same investors who charged into OpenAI’s $40 billion raise in March 2025 and then piled another $122 billion in March 2026 — the largest institutional investment round in history at the time — are now showing signs of investment fatigue. In Korean financial circles, the term used is “소화불량” — indigestion. The appetite is still there, but the meal was too large, and the stomach is full.
Anthropic is not immune to this trend. The company raised roughly $100 billion this year, yet the pattern is the same: massive capital inflows followed by diminishing marginal enthusiasm. Even Sam Altman’s other venture, xAI, has encountered its own headwinds, with Galactica-related integration challenges and competitive pressure from Google’s Gemini ecosystem.
The Wider Reckoning
OpenAI’s valuation cut did not happen in a vacuum. It arrived alongside a sharp selloff across American technology stocks, driven in part by tariff uncertainty, macroeconomic headwinds, and growing skepticism about whether AI infrastructure spending can be sustained indefinitely. The question hanging over every boardroom and portfolio meeting is simple: where are the returns?
The answer, so far, is not convincing. Billions have been deployed into data centers, chips, and model development. Revenue streams remain narrower and slower to mature than the investment thesis assumed. Enterprise adoption has been gradual rather than explosive. A recent JPMorgan analysis found that only 23% of surveyed companies had moved AI from pilot to production at scale — and those that had reported mixed results on return on investment. When a company as dominant as OpenAI feels compelled to adjust its expectations downward, it forces the market to re-examine the assumptions underpinning the entire sector.
The second-order effects are already visible. Venture capital firms that had reserved entire funds for AI startups are now reallocating capital toward climate tech, biotech, and traditional enterprise software. Public markets have begun pricing in the possibility that the “AI capex supercycle” may not deliver the linear returns promised. Nvidia’s stock, which had surged on the back of AI chip demand, has experienced a notable correction as analysts question whether data center spending can continue at current growth rates without corresponding revenue expansion.
This is not the end of the AI investment cycle. But it is the end of the cycle in which anyone could attach the word “AI” to a pitch and raise unlimited capital. The next phase rewards durability over dazzle.
Who Wins, Who Loses
The investors who entered early — and exited or repositioned before this round — win. They locked in returns at valuations that now look generous, and they avoided the discomfort of participating in a down-round that signals collective nervousness. SoftBank’s Vision Fund 2, which invested $4 billion in OpenAI in 2023 at a $29 billion valuation, stands to realize extraordinary paper gains even if the IPO prices closer to $1.25 trillion than $1.4 trillion.
Late-stage investors face a harder reality. The $1.25 trillion valuation may still look impressive on paper, but it represents a step back from the optimism that justified the prior pricing. For those committing fresh capital at this round, the risk-reward calculus has shifted: they are betting that OpenAI can deliver compounding value at a number that was already stretched, and that the broader market will reward AI exposure with the same fervor it displayed two years ago.
That bet is not irrational. But it is no longer a free option.
The bigger losers may be the narrative itself. For years, the story was simple: AI will change everything, and the companies building it are worth a premium for it. The valuation cut complicates that story. It introduces doubt into a sector that ran on certainty.
What Happens Next
OpenAI’s path to IPO next year will be the test. A successful listing at or near the new valuation would validate the company’s pivot toward pragmatism. A stumble — whether from poor timing, weak demand, or broader market turbulence — would send a sharper message through the tech ecosystem.
Several structural shifts are already underway. Regulatory scrutiny is intensifying: the European Union’s AI Act is beginning to take effect, and U.S. lawmakers are pushing for federal oversight frameworks. These developments add compliance costs and potential liability that were not fully priced into earlier valuations. Meanwhile, the talent war that fueled rapid hiring is cooling — engineers who received multiple offers at dizzying compensation packages two years ago are now receiving fewer, and startups that couldn’t compete on salary are finding it easier to attract senior talent.
The broader implication is already unfolding. Capital that once flowed indiscriminately into AI startups is now being scrutinized, measured, and in some cases, withheld. The companies that survive this correction will be those that can demonstrate tangible progress beyond the buzzword. The ones that do not will become cautionary footnotes in the history of a boom that outran its earnings.
OpenAI’s valuation cut is not the end of the AI era. It is the moment the era grew up — forced to confront the gap between its promises and its present reality, and to rebuild on firmer ground.